Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aclaris Therapeutics, Inc.

NASDAQ: ACRS · Life Sciences · 5 alerts · CIK 1557746

Aclaris Therapeutics, Inc. stories on ALFA USA NewsRead the news →
Share price
$3.61Close, Nov 16
Market cap
$572M
Shares outstanding
158.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aclaris Therapeutics, Inc. filings on SEC EDGAR ↗

5:26 PM ET 8-K
Capital Raise

Aclaris Therapeutics Capital Raise of $50M

Aclaris Therapeutics entered into an underwriting agreement to sell 7,785,714 shares of common stock and pre-funded warrants for 6,500,000 shares at a price of $3.50 per share. The company expects to receive gross proceeds of approximately $50 million ($46.7 million net) to fund its operations. The offering is expected to close on October 28, 2026.

Value
$50M
Counterparty
Leerink Partners LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.